Edna Ku Salinas, MD, PH.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2809 Olive Hwy, Ste 150, Oroville, CA 95966 Phone: 530-532-8180 |
Dr. Martin Majer, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2809 Olive Hwy, Suite 150, Oroville, CA 95966 Phone: 530-538-3187 Fax: 530-538-3145 |
Richard Vadheim Smith, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2721 Olive Hwy, Ste 12, Oroville, CA 95966 Phone: 530-533-6061 Fax: 530-533-4438 |
News Archive
An incentive-based program that now reaches 4.5 million families in Mexico is associated with lowering the rate of anemia and improving growth in low-income, rural infants and children, according to a study in the June 2 issue of the Journal of the American Medical Association (JAMA), a theme issue on Global Health.
Throughout the pandemic, healthcare workers have seen more than just the lungs affected by COVID-19. Doctors have reported neurological complications including stroke, headache and seizures, but the information is limited to a number of individual reports that are not reflective of a larger population.
Today 15 million persons throughout the world suffer from an ictus every year and 5 million are left with chronic disabilities. TECNALIA designed a system for alleviating neuromuscular disability amongst these patients from their homes and by which these can be permanently supervised by the therapist who will be able to carry out a quantitative evaluation of the therapy. To this end, they have brought together new technologies and entertainment and a greater quality of rehabilitation.
"Up to five million people in Pakistan are at risk from floods this year, partly due to poor reconstruction and the inadequate rehabilitation of survivors who are still reeling from last year's epic deluge, the U.N. said on Wednesday," Reuters reports.
A study conducted by the University of Rochester Medical Center demonstrates that, for certain patient populations, an experimental device that lowers blood pressure may be a cost effective treatment. The implantable device, called Rheos, is in advanced stages of testing for individuals with drug resistant hypertension.
› Verified 9 days ago